Immediate Impact
1 by Nobel laureates 3 from Science/Nature 52 standout
Citing Papers
Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
2024 Standout
Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer
2023 Standout
Works of J Gordon being referenced
Symptom and Quality of Life Improvement in LUX-Lung 8, an Open-Label Phase III Study of Second-Line Afatinib Versus Erlotinib in Patients With Advanced Squamous Cell Carcinoma of the Lung After First-Line Platinum-Based Chemotherapy
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| J Gordon | 288 | 245 | 189 | 244 | 46 | 950 | |
| M Gábor | 125 | 149 | 74 | 98 | 52 | 743 | |
| Ivan Bašić | 19 | 106 | 154 | 88 | 42 | 970 | |
| Ping Liu | 23 | 31 | 156 | 67 | 31 | 987 | |
| Mehrdad Gholami | 25 | 53 | 104 | 22 | 66 | 856 | |
| Yoshimi Ohno | 156 | 129 | 156 | 27 | 60 | 756 | |
| Avneesh Gupta | 32 | 215 | 157 | 15 | 65 | 1.0k | |
| G. Rai | 15 | 81 | 7 | 190 | 41 | 1.1k | |
| Kuldeep Sharma | 12 | 76 | 20 | 41 | 68 | 830 | |
| Ming Zeng | 13 | 119 | 48 | 167 | 68 | 1.1k | |
| Rajesh Kumar | 6 | 75 | 34 | 99 | 62 | 983 |
All Works
Loading papers...